Jamie Perse of Goldman Sachs, Initiated "Tenet Healthcare Corporation" (THC) at Strong Buy on, Mar 1st, 2022.
Jamie has made no other calls on THC in the last 4 months.
There are 9 other peers that have a rating on THC. Out of the 9 peers that are also analyzing THC, 1 agrees with Jamie's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021
These are the ratings of the 8 analyists that currently disagree with Jamie
- Andrew Mok of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $111 on, Thursday, February 10th, 2022
- David Macdonald of "Truist Securities" Upgraded from Hold to Strong Buy and Held Target at $90 on, Wednesday, February 9th, 2022
- Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $100 on, Wednesday, February 9th, 2022
- Sarah James of "Barclays" Maintained at Buy with Increased Target to $99 on, Wednesday, February 9th, 2022
- A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $111 on, Wednesday, February 9th, 2022
- Whit Mayo of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $100 on, Wednesday, February 9th, 2022
- John Ransom of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $120 on, Thursday, January 20th, 2022
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $90 on, Wednesday, November 10th, 2021
